Literature DB >> 11771684

Behaviour of nitinol in osteoblast-like ROS-17 cell cultures.

A Kapanen1, J Ilvesaro, A Danilov, J Ryhänen, P Lehenkari, J Tuukkanen.   

Abstract

Nickel titanium shape memory metal alloy Nitinol (NiTi) has been used in dental wares and in gastrointestinal surgery. Nitinol is a promising implant material in orthopedics, but its biocompatibility, especially in long-term implantation is not confirmed yet. We studied Nitinol's effect on a cell culture model. Comparisons to stainless steel, pure titanium and pure nickel were performed. The effects of Nitinol on cell death rate, the apoptosis rate and the formation of local contacts were studied on rat osteosarcoma cell line ROS-17 in 48-h cultures. The cell death rate was assessed with combined calcein-ethidium-homodimer labelling. The amount of dead cells 1000 cells were as follows: four in the NiTi, 21 in the Stst, 4.8 in the Ti and 51 in the Ni group. In the NiTi and Ti groups, the number of dead cells was significantly lower (p < or = 0.01) than in Ni group. The rate of apoptosis was detected with TUNEL-assay. The assay results were: 1.93 apoptotic cells 1000 cells in the NiTi, 1.1 in the Stst, 2.98 in the Ti and 0.62 in the Ni group. A comparison of these two results shows that 48% of the dead cells were apoptotic in the NiTi, 56.6 in the Stst, 62% in the Ti and only 1.8% in the Ni group. The focal contacts were stained with a paxillin antibody and counted. There were marked differences in the number of focal contacts per unit area compared to NiTi (774 focal contacts): 335 in Stst (p < or = 0.01), 462 in Ti (p < or = 0.01) and 261 in Ni (p < or = 0.005). Our results show that NiTi is well tolerated by the osteoblastic type ROS-17 cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11771684     DOI: 10.1016/s0142-9612(01)00143-0

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

1.  [Use of a nickel-titanium piston with a shape memory feature].

Authors:  D Beutner; K-B Hüttenbrink
Journal:  HNO       Date:  2007-11       Impact factor: 1.284

2.  Cytotoxicity of Ni from Surface-Treated Porous Nitinol (PNT) on Osteoblast Cells.

Authors:  C Pulletikurthi; N Munroe; P Gill; S Pandya; D Persaud; W Haider; K Iyer; A McGoron
Journal:  J Mater Eng Perform       Date:  2011-07-01       Impact factor: 1.819

3.  Comparison of the bone modeling effects caused by curved and straight nickel-titanium intramedullary nails.

Authors:  S Kujala; J Tuukkanen; T Jämsä; A Danilov; A Pramila; J Ryhänen
Journal:  J Mater Sci Mater Med       Date:  2002-12       Impact factor: 3.896

4.  The effect of oxide thickness on osteoblast attachment and survival on NiTi alloy.

Authors:  V Muhonen; R Heikkinen; A Danilov; T Jämsä; J Tuukkanen
Journal:  J Mater Sci Mater Med       Date:  2007-01-13       Impact factor: 4.727

Review 5.  Cytocompatibility of medical biomaterials containing nickel by osteoblasts: a systematic literature review.

Authors:  Marcin Mikulewicz; Katarzyna Chojnacka
Journal:  Biol Trace Elem Res       Date:  2010-08-12       Impact factor: 3.738

6.  Biocompatibility and Inflammatory Potential of Titanium Alloys Cultivated with Human Osteoblasts, Fibroblasts and Macrophages.

Authors:  Jana Markhoff; Martin Krogull; Christian Schulze; Christian Rotsch; Sandra Hunger; Rainer Bader
Journal:  Materials (Basel)       Date:  2017-01-10       Impact factor: 3.623

7.  Stability and in vivo safety of gold, titanium nitride and parylene C coatings on NdFeB magnets implanted in muscles towards a new generation of myokinetic prosthetic limbs.

Authors:  Veronica Iacovacci; Irene Naselli; Alice Rita Salgarella; Francesco Clemente; Leonardo Ricotti; Christian Cipriani
Journal:  RSC Adv       Date:  2021-02-08       Impact factor: 3.361

8.  Embryotoxic and teratogenic effects of nickel in Swiss albino mice during organogenetic period.

Authors:  Shivi Saini; Neena Nair; Mali Ram Saini
Journal:  Biomed Res Int       Date:  2013-07-15       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.